+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Cardiac Marker Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 436 Pages
  • December 2024
  • Region: Global
  • GlobalData
  • ID: 5680706
The Medical Devices sector report, “Cardiac Marker Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Cardiac Marker Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A cardiac marker test is a biomarker test used to diagnose cardiac diseases.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Marker Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Marker Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Marker Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Cardiac Marker Tests Overview
3 Products under Development
3.1 Cardiac Marker Tests - Pipeline Products by Stage of Development
3.2 Cardiac Marker Tests - Pipeline Products by Segment
3.3 Cardiac Marker Tests - Pipeline Products by Territory
3.4 Cardiac Marker Tests - Pipeline Products by Regulatory Path
3.5 Cardiac Marker Tests - Pipeline Products by Estimated Approval Date
3.6 Cardiac Marker Tests - Ongoing Clinical Trials
4 Cardiac Marker Tests - Pipeline Products under Development by Companies
4.1 Cardiac Marker Tests Companies - Pipeline Products by Stage of Development
4.2 Cardiac Marker Tests - Pipeline Products by Stage of Development
5 Cardiac Marker Tests Companies and Product Overview6 Cardiac Marker Tests- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Cardiac Marker Tests - Pipeline Products by Stage of Development
  • Cardiac Marker Tests - Pipeline Products by Segment
  • Cardiac Marker Tests - Pipeline Products by Territory
  • Cardiac Marker Tests - Pipeline Products by Regulatory Path
  • Cardiac Marker Tests - Pipeline Products by Estimated Approval Date
  • Cardiac Marker Tests - Ongoing Clinical Trials
  • Cardiac Marker Tests Companies - Pipeline Products by Stage of Development
  • Cardiac Marker Tests - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Cardiac Marker Tests - Pipeline Products by Stage of Development
  • Cardiac Marker Tests - Pipeline Products by Segment
  • Cardiac Marker Tests - Pipeline Products by Territory
  • Cardiac Marker Tests - Pipeline Products by Regulatory Path
  • Cardiac Marker Tests - Pipeline Products by Estimated Approval Date
  • Cardiac Marker Tests - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 1Drop Diagnostics
  • 2bullMeDiTherapy
  • 3PrimeDx, Inc.
  • A/C Diagnostics LLC
  • Abbott Diagnostics
  • Abbott Point of Care Inc
  • Abionic SA
  • Accel Diagnostics LLC
  • Access Bio Inc
  • ACS Biomarker
  • Adaltis Srl
  • AgPlus Diagnostics LTD
  • Akrivis Technologies LLC
  • Alfa Wassermann Diagnostic Technologies, LLC
  • Alfa Wassermann Inc
  • All India Institute of Medical Sciences
  • Angle Biosciences Inc
  • Anteo Technologies Pty Ltd
  • Applied Proteomics Inc
  • Aqtual Inc
  • Arrayit Corp
  • Arterez Inc
  • Arterial Solutions Inc
  • Aspira Womens Health Inc.
  • Astute Medical Inc
  • Aterovax SA
  • Atonomics A/S (Inactive)
  • Axis-Shield Diagnostics Ltd
  • AXO Science SAS
  • Baker IDI Heart and Diabetes Institute
  • Baylor College of Medicine
  • BBB Technologies Inc
  • Beckman Coulter Inc
  • Behavioral Diagnostics LLC
  • Berg LLC
  • Bertis Inc
  • BG Medicine Inc
  • Bio Preventive Medicine Corp
  • Bio-AMD Inc
  • BioMedomics Inc
  • bioMerieux SA
  • Biosensia Ltd
  • Biostealth, Inc.
  • Biosurfit, SA
  • Biouniversa srl
  • Bluejay Diagnostics Inc
  • Boditech Med Inc
  • Boston Children's Hospital
  • British Heart Foundation
  • Canon Medical Systems Corp
  • Carclo Diagnostic Solutions Ltd
  • CardioGenics Inc
  • Cardior Pharmaceuticals GmbH
  • Carmel Diagnostics Ltd
  • Cavadis BV
  • Cedars-Sinai Medical Center
  • Cellgenex Diagnostics
  • ChemImage Corp
  • China Medical Technologies Inc (Inactive)
  • China Sky One Medical Inc
  • CHIP Diagnostics Inc
  • Co-Diagnostics Inc
  • Cordex Systems, LLC
  • Corgenix Medical Corp
  • CPD, LLC
  • Critical Diagnostics
  • DestiNA Genomics Ltd
  • Diagnorite Innovative Healthcare Pvt Ltd
  • Diagnos Inc
  • Diazyme Laboratories Inc
  • Diomune SL
  • DSC Technologies Inc
  • Duke University
  • Edan Instruments Inc
  • Edan Medical
  • EMD Millipore Corp
  • Emory University
  • Endothelium Scanning Nanotechnology Ltd
  • Epinex Diagnostics Inc
  • ET Healthcare Inc
  • Firalis SAS
  • Flinders University
  • French National Institute of Health and Medical Research
  • G Medical Health and Wellness
  • genedrive plc
  • Genesis Detection Systems, Inc.
  • Global Genomics Group LLC
  • GlyCardial Diagnostics SL
  • Grifols SA
  • Group K Diagnostics
  • Guangzhou Wondfo Biotech Co Ltd
  • Handok-Kalos Medical
  • Hannover Medical School
  • HealthCheck Diagonstics Inc
  • Hemex Health Inc
  • HTG Molecular Diagnostics Inc
  • Hunan Lezhun Zhixin Biotechnology Co Ltd
  • Infigo Diagnostics Ltd (Inactive)
  • Inflammatix Inc
  • infYnity biomarkers S.A.S.
  • Insilicos LLC
  • Institute of Metabolic and Cardiovascular Diseases
  • Intelligent Optical Systems, Inc.
  • Inverness Medical Canada Inc. (Inactive)
  • iXensor Co. Ltd.
  • Johns Hopkins University
  • Joslin Diabetes Center
  • Kience Inc
  • KineMed Inc
  • Laboratory Corp of America Holdings
  • LeukoDx Ltd
  • LifeArc
  • LightDeck Diagnostics Inc
  • LumiraDx Ltd
  • MagBiosense Inc
  • Magnisense SAS
  • Mayo Clinic
  • McMaster University
  • Mediomics, LLC
  • MedMira Inc
  • MetaboGen AB
  • Metanomics Health GmbH
  • Metasight Diagnostics Ltd
  • MiRXES Pte Ltd
  • MML Ltd
  • MyCartis NV
  • Mylab Discovery Solutions Pvt Ltd
  • NanoLab Inc
  • Nanomix Inc
  • Nanosphere Inc (Inactive)
  • Nanostics Inc
  • National Center for Cardiovascular Research Carlos III
  • National Technology and Engineering Solutions of Sandia LLC
  • Neuome Peptides Pte Ltd
  • Nirmidas Biotech Inc
  • NorthShore University Health System
  • Nuclea Biotechnologies Inc. (Inactive)
  • Numares AG
  • Ohmx Corp
  • OPKO Health Inc
  • Orbit Genetics Inc
  • Ortho Clinical Diagnostics Holdings Plc
  • OSLER Diagnostics Ltd
  • Paperdrop Diagnostics SL
  • Parque Científico de Madrid
  • Pearsanta Inc
  • Persuasive BV
  • PixCell Medical Technologies Ltd
  • Prevencio Inc
  • Prognosys LLC
  • Prolight Diagnostics AB
  • Prolocor Inc.
  • Proplex Technologies Llc
  • Propria LLC
  • Proteome Sciences Plc
  • Proxim Diagnostics Corp
  • Psyros Diagnostics Ltd
  • Pulmokine Inc
  • QLIDA Diagnostics
  • Queen's University Belfast
  • Quidel Corp
  • Radiometer Medical ApS
  • Radisens Diagnostics Ltd
  • Randox Laboratories Ltd
  • Resdin Technologies Inc.
  • Rheonix Inc
  • Roche Diagnostics Corp
  • Roche Diagnostics International Ltd
  • ROS Technologies, Inc
  • Salignostics Ltd
  • Sanofi
  • Sarissa-Biomedical Ltd
  • SDIX LLC
  • Selfa, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Shineco Inc
  • Siemens Healthcare Diagnostics Inc
  • Siemens Healthineers AG
  • Singulex Inc
  • SomaLogic Inc
  • Soroka University Medical Center
  • Sphingotec GmbH
  • SpinChip Diagnostics AS
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • StageZero Life Sciences Ltd
  • Stanford University
  • T2 Biosystems Inc
  • Tcoag Us Inc
  • Tethys Bioscience Inc (Inactive)
  • The Centre of Excellence for Prevention of Organ Failure
  • The Cleveland Clinic Foundation
  • The University of British Columbia
  • Thermo Fisher Scientific Inc
  • ThreeFold Sensors (Inactive)
  • Tosoh Bioscience Inc
  • Trinity Biotech Plc
  • U.S. Department of Veterans Affairs
  • Unity Health Toronto
  • University College Dublin
  • University Hospital of Lyon
  • University of Adelaide
  • University of Alberta
  • University of Arizona
  • University of Birmingham
  • University of California San Diego
  • University of California San Francisco
  • University of Colorado
  • University of Connecticut
  • University of Illinois
  • University of Illinois at Chicago
  • University of Montreal
  • University of Nebraska
  • University of Nice Sophia Antipolis
  • University of Oslo
  • University of Otago
  • University of Pennsylvania
  • University of Saskatchewan
  • University of Texas Medical Branch at Galveston
  • University of Texas Southwestern Medical Center
  • University of Tokyo
  • University of Turku
  • University of Vermont
  • UpFront Diagnostics Ltd
  • Uppsala University
  • Upstream Medical Technologies Ltd
  • Vall d’Hebron Institute of Research
  • Vega Russia
  • Vital Diagnostics, Inc. (Inactive)
  • Washington University School of Medicine
  • XCellCure, LLC
  • Zymo Research Corp